Japanese Study Shows Link Between Green Tea Drinkers and Lower Death Risk
Sept. 12, 2006 -- People who drink at least a pint of green tea each day have a lower risk of death, a Japanese study shows.
The lower overall death risk among green tea drinkers appears to be due to a lower risk of death from. And the benefit of green tea is especially pronounced in women, find Shinichi Kuriyama, MD, PhD, Tohoku University School of Public Policy in Sendai, Japan, and colleagues.
Green tea is a very popular drink in Japan. But some people drink more than others do. Women who drink five or more 3.4-ounce cups of green tea every day cut their risk of heart disease by 31% compared with women who drink one or fewer 3.4-ounce cups. Men who drink this much green tea cut their heart disease risk by 22%.
"Green tea may prolong your life through reducing heart disease and," Kuriyama tells WebMD. "Our findings might explain the differences in mortality profile between Japan and the United States. The Japanese age-adjusted rate of mortality due to [heart disease and stroke] is about 30% lower than that of the United States."
The findings appear in the Sept. 13 issue of The Journal of the American Medical Association.
Green Tea: Might Americans Benefit?
Kuriyama's study is based on data collected since 1994 among more than 40,000 healthy Japanese people aged 40 to 79. More than 86% of the study participants remained in the study for 11 years. Participants filled out detailed questionnaires about their daily diets and health.
The study was conducted with meticulous care. But Kuriyama is quick to point out that this kind of study can't prove green tea has any beneficial effect. Proof comes only from a clinical trial in which some people get green tea and others do not. The Kuriyama study shows only that there is a link between green tea and lower death risk -- not that green tea causes lower death risk.
Alice H. Lichtenstein, DSc, director of the cardiovascularresearch program at Tufts University's Jean Mayer USDA Human Nutrition Research Center on Aging, is underwhelmed by the Kuriyama study.